# Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

> **NCT00182650** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 5 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** rituximab
- **BIOLOGICAL:** therapeutic autologous lymphocytes
- **DRUG:** fludarabine phosphate

## Key facts

- **NCT ID:** NCT00182650
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2009-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182650, "Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00182650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*